Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumor

Explore clinical trials studying Metastatic Solid Tumor. Study availability and eligibility vary by location and protocol.

84 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumor trial results

Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT06440005

Conditions
Advanced Cancer, Angiosarcoma, Breast Cancer, +46 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialist Sarasota, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sarah Cannon Research Center Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

NCT07602842

Conditions
Advanced Solid Tumor, Anus Diseases, Anus Neoplasms, +33 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • START New York Long Island Lake Success, New York, United States
  • START Dallas Forth Worth Fort Worth, Texas, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

NCT07213830

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • South Texas Accelerated Research Therapeutics (START) - Midwest Grand Rapids, Michigan, United States
  • Sarah Cannon Research Institute - Tennessee Oncology Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics (START) - San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

NCT07213817

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Yale Cancer Center-Yale University New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

NCT06803680

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Adventhealth Celebration, Florida, United States
  • Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
  • Next Oncology San Antonio, Texas, United States
View Trial Details
Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

NCT05875168

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
  • University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View all 36 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details

Related conditions